Pricing Log in Create free account
Saturday 17 October 2026 Export TCMD’s income statement to Excel — free account

Tactile Systems Technology, Inc.

TCMD Healthcare Medical Devices

Tactile Systems Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $329.5 million, up 12.5% from fiscal 2024. In the quarter to June 2026, revenue grew 8.61%, EPS grew 142.9% and free cash flow fell 86.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

22.52 0.77 −3.31%
Market cap
$527.6M
P/E
20.5×
Fwd P/E
22.7×
Dividend yield
—
F-score
8/9
Altman Z
9.61
Beneish M
−2.82
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 2.02
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — 1 6 — — 1 — — 1 — —
Insider Ownership 3.43%

Capital & Financial Ratios $m

Market Cap 527.57
Revenue 350.31
Net Income 24.87
Free Cash Flow 26.67
Net Debt (84.78)
Current Ratio 4.12 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 20.47
Fwd P/E 22.70
P/S ratio 1.46
P/B ratio 2.28
Past 5Y EPS Growth —
This Y EPS Growth 36.18% (at or above 15%: strong)
Next Y EPS Growth 37.31% (at or above 15%: strong)
Next Y revenue growth 9.98%
Next 5Y EPS Growth 37.68% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.3×, against a ten-year median of 2.0×; over the ten years it ranged from 0.4× in 2016 to 10.1× in 2018.
P/E against its own 10 years 20.69%
10-year low 10-year high
P/S against its own 10 years 32.06%
10-year low 10-year high
P/B against its own 10 years 30.38%
10-year low 10-year high
EV/Sales against its own 10 years 32.76%
10-year low 10-year high
EV/FCF against its own 10 years 37.26%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 75 109 99 85
Receivables 43 45 44 44
Inventory 23 19 14 17
Other — — — —
145 178 165 158
2023 2024 2025 Q'26
Payables 7 6 5 8
ST’ Debt — — — —
Other 4 3 3 3
41 41 41 38

Compound Annual Growth %

10y 5y 3y
Sales 18.02% 11.98% 10.12%
Cash Flow 33.40% 72.61% 101.81%
Earnings 0.00% 0.00% 0.00%
Book Value 23.15% 11.90% 21.71%

Revenue $m

Mar Jun Sep Dec Year
’26 75 86 — — —
’25 61 79 86 104 330
’24 61 73 73 86 293
’23 59 68 70 78 274
’22 48 60 65 74 247
’21 43 51 52 62 208
’20 44 35 49 59 187
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 0 3 — — —
’25 0 15 10 17 43
’24 1 13 10 16 41
’23 (1) 14 4 18 36
’22 (3) 2 2 4 5
’21 (1) (1) (1) 6 3
’20 1 (9) 6 5 3
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (1) 2 — — —
’25 0 14 9 17 40
’24 0 13 9 16 38
’23 (1) 13 4 17 33
’22 (3) 2 1 4 3
’21 (1) (2) (2) 5 0
’20 1 (9) 5 5 1
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.08) 0.34 — — —
’25 (0.13) 0.14 0.36 0.46 0.82
’24 (0.09) 0.18 0.21 0.40 0.70
’23 (0.09) 0.00 0.94 0.35 1.23
’22 (0.78) (0.23) (0.11) 0.23 (0.89)
’21 (0.12) 0.07 (0.17) (0.38) (0.60)
’20 (0.07) (0.72) 0.12 0.61 (0.03)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 10.00 14.37 27.04 40.62 29.47 18.49 6.28 9.70 11.12 8.61

Analyst estimates 2026–2028

Powerpack
High 22.29 37.88 73.24 76.63 70.19 64.53 21.62 26.11 21.10 30.24
People
People Employees 335 406 499 629 707 988 982 992 1,037 1,086
Revenue/emp, $m 0.25 0.27 0.29 0.30 0.26 0.21 0.25 0.28 0.28 0.30
Income, $m
Income, $m Revenue 85 109 144 189 187 208 247 274 293 330
Gross margin, % 72.87 73.45 71.14 70.84 70.97 71.24 71.31 71.11 73.96 75.91
EBT 4 4 3 11 (2) (2) (15) 16 23 31
EBT margin, % 5.10 3.83 2.42 5.87 (1.21) (1.10) (6.27) 5.75 8.02 9.51
Net income 3 6 7 11 (1) (12) (18) 29 17 19
Depreciation 1 2 4 3 3 4 6 7 7 7
Per share, $
Per share, $ Revenue 9.49 6.30 7.88 10.02 9.67 10.55 12.30 11.97 12.27 14.41
Earnings 0.18 0.34 0.36 0.58 (0.03) (0.60) (0.89) 1.24 0.71 0.83
Cash flow 0.79 0.24 0.49 0.13 0.14 0.13 0.26 1.56 1.70 1.87
Capex (0.09) (0.22) (0.52) (0.32) (0.12) (0.12) (0.10) (0.11) (0.10) (0.11)
Free cash flow 0.70 0.02 (0.03) (0.18) 0.03 0.01 0.16 1.46 1.60 1.76
Book value 6.69 4.19 4.89 5.95 6.45 6.50 6.05 8.45 9.07 9.57
Shares, m 9 17 18 19 19 20 20 23 24 23
Valuation, ×
Valuation, × P/E 297.35 87.00 124.05 116.40 0.00 0.00 0.00 11.81 24.47 34.12
P/S 1.66 4.70 5.78 6.74 4.65 1.80 0.96 1.19 1.40 2.01
P/B 2.35 7.05 9.31 11.34 6.97 2.93 1.96 1.69 1.89 3.03
EV/Sales 1.16 4.30 5.46 6.54 4.44 1.86 1.00 1.01 1.10 1.78
EV/FCF 15.86 1,261.97 (1,457.41) (356.23) 1,650.65 1,399.75 74.44 8.31 8.48 14.55
Cash, $m
Cash, $m Operating cash flow 7 4 9 3 3 3 5 36 41 43
Capex (1) (4) (10) (6) (2) (2) (2) (2) (2) (3)
Free cash flow 6 0 (1) (3) 1 0 3 33 38 40
Balance, $m
Balance, $m Working capital 50 62 69 87 97 79 55 104 137 124
Total debt 0 0 0 15 19 52 46 26 23 —
Net debt (42) (44) (46) (38) (39) 11 8 (49) (86) (99)
Shareholders’ equity 60 73 89 113 125 128 121 194 217 219
Returns, %
Returns, % ROA 2.94 7.21 6.77 8.48 (0.38) (5.65) (7.16) 10.63 5.85 6.67
ROIC 14.88 8.44 4.31 8.83 (2.65) (0.79) (6.17) 7.80 10.59 15.29
ROE 6.05 8.84 8.17 10.87 (0.52) (9.34) (14.31) 18.10 8.27 8.77
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Tactile Systems Technology, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
PACB Pacific Biosciences of California, Inc. $609.2M — (loss-making) — (loss-making) −1.91% (below 0%: shrinking) n/m −30.97% (below 0%: shrinking) 32.40% (114.36%) Compare
KIDS OrthoPediatrics Corp. $589.3M — (loss-making) — (loss-making) +15.43% (above 0%: growing) n/m +77.59% (above 0%: growing) 74.27% (5.77%) Compare
TCMD Tactile Systems Technology, Inc. $527.6M 20.5× 22.7× +8.61% (above 0%: growing) +142.86% (above 0%: growing) −86.53% (below 0%: shrinking) 76.25% 7.97%
SSII SS Innovations International, Inc. $517.2M — (loss-making) — (loss-making) +39.39% (above 0%: growing) n/m −16.62% (below 0%: shrinking) 50.94% (16.29%) Compare
DCTH Delcath Systems, Inc. $513.9M 1,408× — (loss-making) +20.60% (above 0%: growing) −12.50% (below 0%: shrinking) −24.45% (below 0%: shrinking) 89.75% 8.22% Compare
MASS 908 Devices Inc. $491.5M — (loss-making) — (loss-making) +23.31% (above 0%: growing) n/m +150.95% (above 0%: growing) 51.90% (79.69%) Compare
SGHT Sight Sciences, Inc. $484.8M — (loss-making) — (loss-making) +19.55% (above 0%: growing) n/m +26.71% (above 0%: growing) 91.39% (16.62%) Compare
BWAY Brainsway Ltd. Sponsored ADR $475.8M 24.8× — (loss-making) +35.43% (above 0%: growing) +40.00% (above 0%: growing) −51.68% (below 0%: shrinking) 74.62% 13.98% Compare
CERS Cerus Corporation $455.5M — (loss-making) — (loss-making) +5.28% (above 0%: growing) n/m −20.90% (below 0%: shrinking) 55.91% (2.94%) Compare
Median of peers $502.7M — — +20.07% — −18.76% 65.09% (11.03%)

All 149 Medical Devices stocks →

Tactile Systems Technology, Inc. (TCMD) key facts

  • Strength: Tactile Systems Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $329.5 million, up 12.5% from fiscal 2024.
  • Tactile Systems Technology, Inc. (TCMD) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, TCMD traded at $22.52, a market capitalization of $527.6 million.
  • Return on equity was 8.77% and debt-to-equity 0.00.
  • Its Piotroski F-score is 8 out of 9 and its Altman Z-score is 9.61 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Tactile Systems Technology, Inc. (TCMD) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/TCMD · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com